Security key
14161Y200
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL)
CUSIP: 14161Y200
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Class A Common Shares
- Total 13F shares
- 7,719,601
- Total 13F value
- $7,435,013
- Share change
- +226,300
- Put/Call ratio
- 6.6%
- SEC-reported price per share
- $0.97
- Number of holders
- 38
- Value change
- +$182,305
- Number of buys
- 18
- Number of sells
- 18
- Shares outstanding
- 121,080,108
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
38
Top holders
10
CRDL full security history
Ownership snapshot
Full 13F holder table
Cardiol Therapeutics Inc. SEC filings
Cardiol Therapeutics Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of CRDL - Cardiol Therapeutics Inc. - Class A Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Tejara Capital Ltd
Disclosed value leader
Tejara Capital Ltd
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 2.6%
Showing 1-6 of 15 holder rows.
Quick read
Tejara Capital Ltd leads the comparable SEC ownership view at 2.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Tejara Capital Ltd's linked filing trail.
Comparable ownership
Top 5
Tejara Capital Ltd
2.6%
AdvisorShares Investments LLC
0.73%
MMCAP International Inc. SPC
0.66%
PVG ASSET MANAGEMENT CORP
0.4%
Cambridge Investment Research Adv...
0.27%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Tejara Capital Ltd |
13F
Company
|
2.6%
|
$3,987,759
3,115,437 shares
|
— | 31 Dec 2024 |
| AdvisorShares Investments LLC |
13F
Company
|
0.73%
|
$1,129,585
882,488 shares
|
— | 31 Dec 2024 |
| MMCAP International Inc. SPC |
13F
Company
|
0.66%
|
$1,018,400
795,625 shares
|
— | 31 Dec 2024 |
| PVG ASSET MANAGEMENT CORP |
13F
Company
|
0.4%
|
$623,737
487,295 shares
|
— | 31 Dec 2024 |
| Cambridge Investment Research Advisors, Inc. |
13F
Company
|
0.27%
|
$424,000
330,505 shares
|
— | 31 Dec 2024 |
| ENVESTNET ASSET MANAGEMENT INC |
13F
Company
|
0.26%
|
$398,067
309,684 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
38
Shares
7,719,601
Rows available
38
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
38
Q1 2025 holders
38
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|